Biomedical Research

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Reach Us +44-7360-538437

Rapid Communication - Biomedical Research (2018) Volume 29, Issue 12

The impact of calibration on medical devices performance and patient safety

Altayyar Saleh S1*, Mousa MA2, Alfaifi AM2, Negm AE2 and Ali MO2

1Department of Biomedical Technology, College of Applied Medical Sciences, King Saud University, Riyadh, Saudi Arabia

2Healthcare Technology Management Administration, King Fahad Medical City, Ministry of Health, Riyadh, Saudi Arabia

*Corresponding Author:
Altayyar Saleh S
Department of Biomedical Technology
College of Applied Medical Sciences
King Saud University
Riyadh, Saudi Arabia

Accepted date: May 07, 2018

DOI: 10.4066/biomedicalresearch.29-18-550

Visit for more related articles at Biomedical Research

Abstract

Hospitals and health care providers are striving to reduce health care cost without compromising the quality of health care and appropriate medical diagnosis. They are becoming more aware of the importance of medical devices calibration in their health care facilities, and the impact it has on both the quality of health services provided to the patients, and patient’s safety. Healthcare providers are beginning to realize that the maintenance of medical devices alone, without assuring proper calibration, may not be sufficient enough to ensure proper function, adequate and reliable measurements. Accurate and reliable measurements are crucial for appropriate medical decisions. On the contrary, un-calibrated medical devices may lead to imprecise measurements. These measurements will have a significant negative impact on the quality of the healthcare provided to patients and might increase the healthcare cost by subjecting patients to excessive medical treatment. The study was conducted on a representative sample of 20.5% from total asset (1034) of high risk medical devices representing 6 devices categories. The objective of this study is to examine the impact of calibration of medical devices on performance and patient’s safety by investigating devices performance against international standard reference or manufacturer recommendations. 34% of the sample failed the visual test, 5% failed the safety test, and 58% failed the performance test. However, it is important to note that there was no death or serious incidents associated with these devices. In conclusion, these devices do not meet the international standard and continued use of such devices can compromise patient’s safety.

Keywords

Patient’s safety, Performance, Calibration, Medical devices accuracies

Introduction

The medical devices industry has grown rapidly and incessantly over the past century. The sophistication and complexity of the designed instrumentation is nowadays rising and, with it has also increased the need to develop some better, more effective and efficient maintenance processes, as part of the safety and performance requirements [1]. For the health industry, be it hospitals or manufacturers of medical devices, nothing counts more than the safety of a patient [2]. Therefore all quality conscious hospitals consider the periodic testing and calibration of devices, a permanent feature in their quality control regimen that they strictly adhere to. It is a significant mark to their dedication and commitment to quality and continuous improvement. Testing and calibration of devices ensures accuracy, effectiveness in diagnosis and treatment and long life of devices, which ultimately enables one to achieve the highest degree of quality control and patient safety. Medical errors are a recognized cause of harm in the health care system, but clinical measurement errors are seldom, if ever, identified as causes of adverse events [3]. In recent years, a growing number of patients have suffered from adverse events due to medical devices malfunction [4]. In addition to knowledge and experience of medical doctors, correct diagnosis and appropriate patient treatment largely depend on accuracy and functionality of medical devices. In a large number of serious medical situations, devices proper functionality of medical devices is crucial for patients. Therefore it is necessary to carry out as strict and independent testing of functionalities of medical devices as possible and to obtain the most accurate and reliable diagnosis and patient treatment [5]. The objective of this paper is to examine the impact of calibration on medical devices performance and patient’s safety by investigating the performance of selected sample of medical devices against international standard reference or manufacturer recommendations.

Methodology

This research is designed to determine the clinical significant of un-calibrated medical devices in health care facilities. Further, the research will investigate and evaluate the activities of medical devices function against standard reference. Due to the impact of medical devices bad performance on patient’s safety and the quality of health services provided to patients, the main target here is patient safety and medical devices performance. The test is performed on site in different clinical departments of a major hospital in Saudi Arabia. The department and devices were selected randomly as per their availability. The concept of research project design and methodology are shown in Figure 1.

biomedres-Research-design

Figure 1: Research design flowchart.

The study was conducted on a representative sample of 21% from total asset (1034) of high risk medical devices representing 6 devices categories. The devices are infant incubators, transport incubators, warmers, defibrillators, electrocardiogram (ECG) and vital signs monitor. Each of the devices under test (DUT) was subjected to a sequence of tests in accordance to IEC60601, IEC 62353, and ISO 17025 [6-8]. The sequence of test cycle include: visual inspection, electrical safety testing and performance test. The process of visual inspection is not clearly defined by IEC 60601, however it is a relatively easy procedure to make sure that the medical devices in use still conforms to the specifications as released by the manufacturer and has not suffered from any external damage and/or contamination [9]. These can include the following inspections: housing enclosure, contamination, cabling, fuse rating (check correct values after replacement), markings and labelling, and Integrity of mechanical parts.

Electrical safety test is performed in accordance to IEC 60601 and IEC 62353. Performance Test is performed according to international standards or manufacturer recommendations by using the suitable calibrated and traceable standard reference(s) or test devices [10,11]. Both the safety and performance of the DUT will be subjected to assessment based on technical comparisons against international standards or manufacturer recommendations, which sets the limit for pass and fail acceptance criteria [12-21]. The limit used to decide the DUT pass/fail criteria is shown in Table 1. The test is performed by ISO 17025 certified biomedical engineers, who are also certified by Fluke biomedical advantage training on the use of test equipment. The test equipment used is calibrated and is shown in Table 2. These test equipment were found to meet Fluke biomedical manufacturing specifications as per the test equipment calibration certificate.

Measurements Standard Limit
Incubator IEC60601-2-19/60601-2-20 Baby Transport
Sound level 201.9.6.2.1.101 ≤ 60 dB ≤ 60 dB
Stability of temp 201.12.1.101 ± 0.5°C ± 1.0°C
Uniformity of temp 201.12.1.102 ± 0.8°C 1.5°C
Skin temp 201.12.1.103 ± 0.3°C ± 0.3°C
Accuracy of indicator 201.12.1.105 ± 0.8°C ± 1.5°C
Temp control accuracy 201.12.1.106 ± 1.5°C ± 1.5°C
Overshoot 201.12.1.108 ≤ 2°C ≤ 2°C
RH accuracy 201.12.1.109 ± 10% ± 15%
Air flow 201.12.1.111 ≤ 0.35 m/s ≤ 0.35 m/s
Radiant warmers
Distribution accuracy 201.9.6.2.1.102   ± 2°C
Operating accuracy 201.12.1.103   ± 0.5°C
Skin sensor accuracy 201.9.6.2.1.101   ± 0.3°C
Vital signs
ECG rate Fluke biomedical   ± 5%
Respiration rate Fluke biomedical   ± 5%
NIBP IEC 80601-1-2-30   ± 10 mmHg
SpO2 ISO 80601-2-61:2011   ± 3%
Defibrillator
Paddle continuity test Fluke biomedical   ≤ 0.15 Ω
Heart rate accuracy Fluke biomedical   ± 5%
Recorder speed Fluke biomedical   ± 4%
Testing energy Fluke biomedical   ± 15%
Energy after 60 s of full charge Fluke biomedical   ≥ 85%
Synchronization test Fluke biomedical   ≤ 60 ms
Battery test@360 J Fluke biomedical   ± 15%
Charge time Fluke biomedical   ≤ 15 s
ECG
Lead alarm Fluke biomedical   Observe
Heart rate accuracy IEC 60601-2-27   ± 5%
Paper speed Fluke biomedical   ± 4%
Frequency test Fluke biomedical   Observe
ECG artefact Fluke biomedical   Observe
Overshoot Fluke biomedical   ± 1 mm
Damping Fluke biomedical   ± 1 mm
Alarm test IEC 60601-2-27   10 s
Electrical safety test
Voltage live to neutral IEC EN 62353   ± 10% (V)
Voltage neutral to earth IEC EN 62353   ± 10% (V)
Voltage live to earth IEC EN 62353   ± 10% (V)
Protective earth resistance IEC EN 62353   <0.3 (Ω)
Insulation resistance IEC EN 62353   <2 M (Ω)
Enclosure leakage current closed earth IEC EN 62353   <1000 μA class I, <500 μA class II
Applied part leakage current IEC EN 62353   <500 μA class II, <50 μA CF

Table 1. Pass/fail criteria.

Measured quantity Range Accuracy
Measurement of electrical safety parameters
Voltage 0 to 300 V ac rms ± (2%+0.2 V)
Insulation resistance 0.5 MΩ to 20 MΩ ± (2% of reading+0.2 MΩ)
Current consumption 0 to 20 A ± (5% of reading+(2 counts or 0.2 A, whichever is greater))
Protective earth resistance 0.000 to 2.999 Ω ± (2% of reading+0.015 Ω)
Fluke biomedical, Vital signs simulator, ProSim8
NIBP simulations Adult: 60/30 (40), 80/50 (60); 100/65 (77); 120/80 (93); 150/100 (117); and 200/150 (167) and 255/195 (215) Repeatability within ± 2 MMHG (At maximal pulse size independent of device under test)
Leakage rate 0 to 200 mmHg/min <2 mmHg/min into 500 ml rigid volume
Pressure relief 100 to 400 mmHg ± (0.5+0.5 mmHg)
Heart rate 30-240 BPM ±1 % of setting
Oxygen (%) 35-100% with oximeter manufacturer’s R-curve
Saturation within UUT specific range ± (1 count+specified accuracy of the UUT)
Saturation outside UUT specific range monotonic with unspecified accuracy
With fluke biomedical R-curves 91 to 100% ± (3 counts+specified accuracy of the UUT)
81 to 90% ± (5 counts+specified accuracy of the UUT)
71 to 80% ± (7 counts+specified accuracy of the UUT)
Below 71 % monotonic with unspecified accuracy
Puls rate 30-250 BPM ± 1% of setting
ECG rate 10 BPM to 360 BPM ± 1% of setting
Pulse wave 30, 60 BPM, with 60 ms pulse width ± 1% of setting
Square wave 0.125, 2.0, 2.5 Hz ± 1% of setting
Triangle wave 0.125, 2.0, 2.5 Hz ± 1% of setting
Sine wave 0.05, 0.5, 1, 2, 5, 10, 25, 30, 40, 50, 60, 100 and 150 Hz ± 1% of setting
Width 8 to 20 ms ± (1%+1 ms)
Respiration rate 10 to 150 BrPM ± 5%
Fluke biomedical, Defibrillator/Transcutaneous pacer analyzer, Impulse 7000DP
Delivered energy 0.1-600 Joule ± (1%+0.1 J)
Synchronization -120 to +380 ms ± 1 ms
Charge time 0.1 s to 100 s ± 0.05 s
Calibration of infant incubators and radiant warmer
Temperature 5 to 70°C +0.5°C+1 LSB
Relative humidity 0-100% RH ± 5.3% RH
Sound level 30-80 DB + 5 dbA
Air flow 0.1 to 0.7 m/s ± 0.1 m/s

Table 2. Test equipment.

Calibration measurements are traceable to the National Institute of Standards and Technology (NIST). Devices for which there are no NIST calibrations standards are measured against in-house performance standards using accepted test procedures. The results obtained from the test equipment are recorded in a hardcopy checklist and at the same time, a copy of the electrical safety automatic test sequence is saved in the analyzer and later printed and attached to the hard copy reports to guarantee the data traceability with electronic archival system.

Results

Test results are analyzed and validated according to relative international standard and the manufacture specification. The medical devices under test with all valid test results are assigned to, which contains all the DUTs that passed visual, safety and performance test, while the DUT that failed to pass any of the tests will be assigned to as shown in Table 3. The errors of each type of medical device were investigated. The percentage of errors is shown in Table 4. Thus, it is possible to see which error occurs in which ratio. Figures 2 to 7 show the results of each type of selected devices.

biomedres-infant-incubators

Figure 2: Results of infant incubators.

biomedres-Results-incubators

Figure 3: Results of transport incubators.

biomedres-Results-warmers

Figure 4: Results of warmers.

biomedres-Results-ECG

Figure 5: Results of ECG.

biomedres-Results-defibrillators

Figure 6: Results of defibrillators.

biomedres-vital-signs

Figure 7: Results of vital signs monitor.

Medical devices Visual test % Safety test % Performance test %
Infant incubators 100 0 64
Transport incubators 67 0 83
Warmers 40 0 60
ECG 39 11 56
Defibrillator 5 2 19
VitalSigns monitor 35 6 70

Table 3. Test results of DUT failed.

DUT Total of DUT Errors Number of errors (%)
Infant incubators 11 No skin probe 73
Fan noise 36
Display 18
Temp control damage 9
Water tank 18
Skin accuracy 9
Transport incubators 6 Skin probe 34
Windo cover 17
Warmers 10 No skin probe 40
Heater stop@33°C 10
Control key damage 10
ECG 18 Lead broken 28
Power cable 11
Printer broken 6
Defibrillator 42 Recorder speed need to adjust 17
Printed ECG Unclear 7
Protective earth resistance 2
VitalSigns monitor 125 Caring handle broken 2
NIBP cuff 4
ECG lead 3
Power cable 4
Printer broken 0.8

Table 4. The errors of failed DUT.

In examine the efficiency of medical devices to ensure their performance in accordance with international standards and to determine deviations in measurement. The study showed that there is a difference in the results of visual test, safety test and performance test. 22% of the total assets of infant incubators were tested and 100% of them failed the visual test, 0 % of them failed safety test and 64% of them failed the performance test as showed in Figure 2.

All transport incubators devices were tested and 67% of them failed visual test, 0% of them failed safety test, and 83% of them failed performance test as shown in Figure 3. 19% of total assets of warmers were tested and 40 % of them failed visual test; 0% of them failed safety and 60 % of them failed performance test as shown in Figure 4.

In our examination, 19 % of total asset of ECG machine were tested and 39% of them failed visual test; 11% of them failed in safety and 56 % of them failed performance test as shown in Figure 5. 20% of the total assets of defibrillator were tested and 5% of them failed the visual test, 2 % of them were failed safety test and 19% of them failed the performance test as showed in Figure 6. A 20% sample of total asset of vital signs monitors were tested and 35% of them failed visual test, 6% of safety test, and 70% failed performance test as shown in Figure 7.

The study reflects a method that can be used to improve the efficiency of medical devices and ensure the quality of their performance in accordance with international standards. We were also able to identify problems for each devices and lack of suitability to international standards.

Discussion

The study shows a large percentage of devices failed the performance test, with the transport incubator having the highest percentage (83.3%) and the defibrillators having the lowest (19%). This is a very high percentage since these devices are high risk and/or life saving devices, which questions their reliability and may compromise patient safety and health.

In comparing the current research with similar studies that have been carried out, among which are Sezdi in Turkey and Almir et al. in Bosnia and Herzegovina.

A study conducted by Sezdi on high risk group medical devices (Table 5) used at the Departments of Operation Room and Intensive Care in Cerrahpasa, Faculty of Medicine in Istanbul University. Results showed 115 medical devices were signed as “Failed” of the total 542 medical devices from different departments which represents 21% [22].

Medical devices Total asset Number of devices failed the test Fail %
Infant incubators 34 6 18
Defibrillator 52 9 17
Ventilator 99 12 12
Anesthesia unit 53 23 43
Electrosurgical unit 59 14 24
Physiological monitor 245 51 21
Total 542 115 21%

Table 5. Test results by Sezdi.

The study by Badnjevic et al. involved 3 clinical centres, 25 hospitals, 63 health centres and 320 private health institutions in Bosnia and Herzegovina over the course of 1 y. The outcome of this study showed 23 of 90 devices (26%) doesn’t meet the error limits requirements (Table 6) [23].

Medical devices Total asset Number of devices failed the test Fail %
ECG Devices 26 6 23
Defibrillator 15 6 40
Anesthesia machine 7 2 29
Incubator 17 4 24
Respirator 7 0 0
Patient monitor 5 1 20
Therapeutic ultrasound 14 6 43%
Total 90 23 26

Table 6. Test results by Badnjević et al.

Conclusions

The objective of this study is to examine the impact of calibration of medical devices performance and patient’s safety. The study found 34% of the total selected sample of medical devices under test from major hospital in Saudi Arabia failed in visual test, 5% failed safety test and 58% failed performance test. This is higher than those reported by the previous two studies conducted by Sezdi et al. which reported failure rate of 21% and 26% respectively.

The study reflects a method that can be used to improve the efficiency of medical devices and ensure the quality of their performance in accordance with international standards. We were also able to identify the problems of each device and lack of suitability to international standards. Accordingly, the expansion of the study in the future to cover all medical devices is very important in order to assess the performance of medical devices in all departments of the hospital. It is important to note that the problems related to the performance test of medical devices in this study did not cause serious accidents or resulted in death, but these devices do not meet international standards and use can be dangerous to the patient because of the risk associated with their performance.

References

Get the App